HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The application of cancer stem cell model in malignant mesothelioma.

Abstract
The high mortality rate of malignant pleural mesothelioma led to study the mechanisms for chemoresistance. The cancer stem cell (CSC) model has been proposed to explain chemoresistance. CSCs are characterized by self-renewal capacity, that is detected through tumor-initiating cell assays. As in other malignancies, many studies sought to identify surface markers to isolate CSCs from malignant mesothelioma. Other studies characterized malignant mesothelioma CSCs for the expression of specific genes involved in stemness and the expression of proteins involved in chemoresistance. However, the main methods to characterize isolated CSCs include sphere formation, invasiveness, tumor-initiating capacity and expression of specific surface markers. The better knowledge of malignant mesothelioma CSCs allowed exploring new potential targets to develop specific treatments.
AuthorsGiuseppe Bronte, Antonio Domenico Procopio, Laura Graciotti
JournalCritical reviews in oncology/hematology (Crit Rev Oncol Hematol) Vol. 174 Pg. 103698 (Jun 2022) ISSN: 1879-0461 [Electronic] Netherlands
PMID35525390 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2022 Elsevier B.V. All rights reserved.
Topics
  • Cell Line, Tumor
  • Humans
  • Mesothelioma (genetics)
  • Mesothelioma, Malignant
  • Neoplastic Stem Cells (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: